IL	0	2	B-Gene_or_gene_product
-	2	3	I-Gene_or_gene_product
12	3	5	I-Gene_or_gene_product
inhibition	6	16	O
of	17	19	O
endothelial	20	31	B-Cell
cell	32	36	I-Cell
functions	37	46	O
and	47	50	O
angiogenesis	51	63	O
depends	64	71	O
on	72	74	O
lymphocyte	75	85	B-Cell
-	85	86	O
endothelial	86	97	B-Cell
cell	98	102	I-Cell
cross	103	108	O
-	108	109	O
talk	109	113	O
.	113	114	O

In	116	118	O
vivo	119	123	O
IL	124	126	B-Gene_or_gene_product
-	126	127	I-Gene_or_gene_product
12	127	129	I-Gene_or_gene_product
-	129	130	O
dependent	130	139	O
tumor	140	145	B-Pathological_formation
inhibition	146	156	O
rests	157	162	O
on	163	165	O
the	166	169	O
ability	170	177	O
of	178	180	O
IL	181	183	B-Gene_or_gene_product
-	183	184	I-Gene_or_gene_product
12	184	186	I-Gene_or_gene_product
to	187	189	O
activate	190	198	O
a	199	200	O
CD8	201	204	B-Gene_or_gene_product
-	204	205	O
mediated	205	213	O
cytotoxicity	214	226	O
,	226	227	O
inhibit	228	235	O
angiogenesis	236	248	O
,	248	249	O
and	250	253	O
cause	254	259	O
vascular	260	268	O
injury	269	275	O
.	275	276	O

Although	277	285	O
in	286	288	O
vivo	289	293	O
studies	294	301	O
have	302	306	O
shown	307	312	O
that	313	317	O
such	318	322	O
inhibition	323	333	O
stems	334	339	O
from	340	344	O
complex	345	352	O
interactions	353	365	O
of	366	368	O
immune	369	375	B-Cell
cells	376	381	I-Cell
and	382	385	O
the	386	389	O
production	390	400	O
of	401	403	O
IFN	404	407	B-Gene_or_gene_product
-	407	408	I-Gene_or_gene_product
gamma	408	413	I-Gene_or_gene_product
and	414	417	O
other	418	423	O
downstream	424	434	O
angiostatic	435	446	O
chemokines	447	457	O
,	457	458	O
the	459	462	O
mechanisms	463	473	O
involved	474	482	O
are	483	486	O
still	487	492	O
poorly	493	499	O
defined	500	507	O
.	507	508	O

Here	509	513	O
we	514	516	O
show	517	521	O
that	522	526	O
IL	527	529	B-Gene_or_gene_product
-	529	530	I-Gene_or_gene_product
12	530	532	I-Gene_or_gene_product
activates	533	542	O
an	543	545	O
anti	546	550	O
-	550	551	O
angiogenic	551	561	O
program	562	569	O
in	570	572	O
Con	573	576	B-Drug_or_compound
A	577	578	I-Drug_or_compound
-	578	579	O
activated	579	588	O
mouse	589	594	B-Organism
spleen	595	601	B-Cell
cells	602	607	I-Cell
(	608	609	O
activated	609	618	O
spc	619	622	B-Cell
)	622	623	O
or	624	626	O
human	627	632	B-Organism
PBMC	633	637	B-Cell
(	638	639	O
activated	639	648	O
PBMC	649	653	B-Cell
)	653	654	O
.	654	655	O

The	656	659	O
soluble	660	667	O
factors	668	675	O
they	676	680	O
release	681	688	O
in	689	691	O
its	692	695	O
presence	696	704	O
arrest	705	711	O
the	712	715	O
cycle	716	721	O
of	722	724	O
endothelial	725	736	B-Cell
cells	737	742	I-Cell
(	743	744	O
EC	744	746	B-Cell
)	746	747	O
,	747	748	O
inhibit	749	756	O
in	757	759	O
vitro	760	765	O
angiogenesis	766	778	O
,	778	779	O
negatively	780	790	O
modulate	791	799	O
the	800	803	O
production	804	814	O
of	815	817	O
matrix	818	824	B-Gene_or_gene_product
metalloproteinase	825	842	I-Gene_or_gene_product
-	842	843	I-Gene_or_gene_product
9	843	844	I-Gene_or_gene_product
,	844	845	O
and	846	849	O
the	850	853	O
ability	854	861	O
of	862	864	O
EC	865	867	B-Cell
to	868	870	O
adhere	871	877	O
to	878	880	O
vitronectin	881	892	B-Gene_or_gene_product
and	893	896	O
up	897	899	O
-	899	900	O
regulate	900	908	O
ICAM	909	913	B-Gene_or_gene_product
-	913	914	I-Gene_or_gene_product
1	914	915	I-Gene_or_gene_product
and	916	919	O
VCAM	920	924	B-Gene_or_gene_product
-	924	925	I-Gene_or_gene_product
1	925	926	I-Gene_or_gene_product
expression	927	937	O
.	937	938	O

These	939	944	O
effects	945	952	O
do	953	955	O
not	956	959	O
require	960	967	O
direct	968	974	O
cell	975	979	B-Cell
-	979	980	O
cell	980	984	B-Cell
contact	985	992	O
,	992	993	O
yet	994	997	O
result	998	1004	O
from	1005	1009	O
continuous	1010	1020	O
interaction	1021	1032	O
between	1033	1040	O
activated	1041	1050	O
lymphoid	1051	1059	B-Cell
cells	1060	1065	I-Cell
and	1066	1069	O
EC	1070	1072	B-Cell
.	1072	1073	O

We	1074	1076	O
used	1077	1081	O
neutralizing	1082	1094	O
Abs	1095	1098	O
to	1099	1101	O
show	1102	1106	O
that	1107	1111	O
the	1112	1115	O
IFN	1116	1119	B-Gene_or_gene_product
-	1119	1120	I-Gene_or_gene_product
inducible	1120	1129	I-Gene_or_gene_product
protein	1130	1137	I-Gene_or_gene_product
-	1137	1138	I-Gene_or_gene_product
10	1138	1140	I-Gene_or_gene_product
and	1141	1144	O
monokine	1145	1153	O
-	1153	1154	O
induced	1154	1161	O
by	1162	1164	O
IFN	1165	1168	O
-	1168	1169	O
gamma	1169	1174	O
chemokines	1175	1185	O
are	1186	1189	O
pivotal	1190	1197	O
in	1198	1200	O
inducing	1201	1209	O
these	1210	1215	O
effects	1216	1223	O
.	1223	1224	O

Experiments	1225	1236	O
with	1237	1241	O
nu	1242	1244	B-Organism
/	1244	1245	I-Organism
nu	1245	1247	I-Organism
mice	1248	1252	I-Organism
,	1252	1253	O
nonobese	1254	1262	B-Organism
diabetic	1263	1271	I-Organism
-	1271	1272	I-Organism
SCID	1272	1276	I-Organism
mice	1277	1281	I-Organism
,	1281	1282	O
or	1283	1285	O
activated	1286	1295	O
spc	1296	1299	B-Cell
enriched	1300	1308	O
in	1309	1311	O
specific	1312	1320	O
cell	1321	1325	B-Cell
subpopulations	1326	1340	O
demonstrated	1341	1353	O
that	1354	1358	O
CD4	1359	1362	B-Gene_or_gene_product
(	1362	1363	O
+	1363	1364	O
)	1364	1365	O
,	1365	1366	O
CD8	1367	1370	B-Gene_or_gene_product
(	1370	1371	O
+	1371	1372	O
)	1372	1373	O
,	1373	1374	O
and	1375	1378	O
NK	1379	1381	B-Cell
cells	1382	1387	I-Cell
are	1388	1391	O
all	1392	1395	O
needed	1396	1402	O
to	1403	1405	O
mediate	1406	1413	O
the	1414	1417	O
full	1418	1422	O
anti	1423	1427	O
-	1427	1428	O
angiogenetic	1428	1440	O
effect	1441	1447	O
of	1448	1450	O
IL	1451	1453	B-Gene_or_gene_product
-	1453	1454	I-Gene_or_gene_product
12	1454	1456	I-Gene_or_gene_product
.	1456	1457	O

